1. Home
  2. CUZ vs ADMA Comparison

CUZ vs ADMA Comparison

Compare CUZ & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUZ
  • ADMA
  • Stock Information
  • Founded
  • CUZ 1958
  • ADMA 2004
  • Country
  • CUZ United States
  • ADMA United States
  • Employees
  • CUZ N/A
  • ADMA N/A
  • Industry
  • CUZ Real Estate Investment Trusts
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CUZ Real Estate
  • ADMA Health Care
  • Exchange
  • CUZ Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • CUZ 4.7B
  • ADMA 5.8B
  • IPO Year
  • CUZ N/A
  • ADMA N/A
  • Fundamental
  • Price
  • CUZ $28.09
  • ADMA $19.98
  • Analyst Decision
  • CUZ Buy
  • ADMA Strong Buy
  • Analyst Count
  • CUZ 9
  • ADMA 4
  • Target Price
  • CUZ $32.56
  • ADMA $24.25
  • AVG Volume (30 Days)
  • CUZ 1.2M
  • ADMA 4.6M
  • Earning Date
  • CUZ 05-01-2025
  • ADMA 05-07-2025
  • Dividend Yield
  • CUZ 4.56%
  • ADMA N/A
  • EPS Growth
  • CUZ N/A
  • ADMA N/A
  • EPS
  • CUZ 0.34
  • ADMA 0.84
  • Revenue
  • CUZ $892,818,000.00
  • ADMA $459,381,000.00
  • Revenue This Year
  • CUZ $11.57
  • ADMA $18.45
  • Revenue Next Year
  • CUZ $4.18
  • ADMA $26.96
  • P/E Ratio
  • CUZ $82.87
  • ADMA $23.91
  • Revenue Growth
  • CUZ 10.04
  • ADMA 62.23
  • 52 Week Low
  • CUZ $22.01
  • ADMA $6.84
  • 52 Week High
  • CUZ $32.55
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • CUZ 53.95
  • ADMA 43.06
  • Support Level
  • CUZ $27.50
  • ADMA $18.75
  • Resistance Level
  • CUZ $28.07
  • ADMA $23.98
  • Average True Range (ATR)
  • CUZ 0.66
  • ADMA 1.38
  • MACD
  • CUZ 0.15
  • ADMA -0.34
  • Stochastic Oscillator
  • CUZ 81.12
  • ADMA 17.77

About CUZ Cousins Properties Incorporated

Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: